We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




NMR Spectrometer Unraveling Disease Processes

By HospiMedica staff writers
Posted on 14 Nov 2006
A newly developed nuclear magnetic resonance (NMR) spectrometer is helping researchers solve submicroscopic mysteries surrounding health and disease.

Dr. More...
Steven Van Doren, associate professor of biochemistry at the University of Missouri-Columbia (MU; MO, USA), is utilizing NMR technology to better understand the structure and movement of proteins, especially those that contribute to cancer, emphysema, aneurysms, and atherosclerosis, which cause heart attacks and strokes. The data can then be used for drug development. Dr. Van Doren's research team is also utilizing the technology to study proteins that plants use to fight infections.

The NMR spectrometer functions similar to a radio, using MHz frequencies and an antenna to transmit and receive signals. However, it is more powerful than a radio, much larger in size, and consists of several components; the most significant is a superconducting magnet, which stands about 10 feet tall. A pencil-sized test tube, containing the research sample, is inserted at the top of the large magnet. Radio waves stimulate the molecules inside the test tube, transmitting radio waves back to the device that are translated into detailed images representing the protein molecules. The images are then displayed on a computer monitor.

Dr. Van Doren's NMR research has resulted in breakthroughs regarding TIMP (tissue inhibitor of metalloproteinase), a protein that promotes the progression of cancer and arthritis. It also inhibits cancer and arthritis by fighting the formation of new blood vessels. TIMP proteins are now being modified to enhance their therapeutic potential. "When you understand the molecular basis of life and disease, you better understand how to interfere with processes that lead to disease,” Dr. Van Doren said.

Dr. Van Doren expects further research advancements when MU acquires a new and more powerful spectrometer. Currently, MU has four spectrometers, which operate at frequencies of 250, 300, 500, and 600 MHz; however, Dr. Van Doren reported that the newest, at 800 MHz, will far outperform the others.

MU's newest superconducting magnet will stand nearly 12 feet tall, weighing nearly 8,000 pounds. "The performance goes up exponentially with the number of MHz,” Dr. Van Doren said. "We'll be able to study much larger assemblies of these molecules of life and tackle much more challenging problems of greater medical, agriculture, and biotechnology interest.”



Related Links:
University of Missouri-Columbia

Gold Member
12-Channel ECG
CM1200B
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Glucose Meter
StatStrip®
Radiofrequency Generator
GX1
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: New findings show that chemotherapy plus immunotherapy before surgery produced greater tumor destruction than immunotherapy alone in head and neck cancer patients (Image Credit: Adobe Stock)

Combination Therapy Before Surgery Drives Stronger Tumor Reduction in Head and Neck Cancer

Patients with head and neck cancer who are scheduled for surgery often face a waiting period with limited treatment, creating an opportunity to reduce viable tumor burden before the operation.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.